Related Experiment Video
Updated: Sep 13, 2025

A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood
Published on: April 28, 2016
The Peptide Paradox in Pharmacology of Obesity
Sanjay Kalra1, Amandeep Singh2, Nitin Kapoor3
1Department of Endocrinology, Bharti Hospital, Karnal, India; University Center for Research & Development, Chandigarh University, Mohali, India.
Abstract:
Peptide biology is a fascinating subject, and peptide pharmacology even more so. Peptides have multiple bodily functions, including their work as hormones and metabolic modulators. However, certain pharmacodynamic and kinetic properties of peptides used in obesity result in paradoxical outcomes. It is helpful for the treating clinician to be aware of these peptide paradoxes, which not only help in understanding the rationale of using these drugs but also help to explain their differences in clinical actions.
Related Concept Videos
Regulation of Food Intake
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
cAMP-dependent Protein Kinase Pathways
Obesity
Hormonal Regulation

